A groundbreaking study of 4 million cases reveals that never-married adults have a significantly higher risk of developing cancer compared to those who are married or previously married. Researchers from the University of Miami uncovered a surprising connection between marital status and cancer incidence that could reshape how we think about health and relationships.
The Damon Runyon Cancer Research Foundation has just announced its latest cohort of Fellows—13 exceptional postdoctoral researchers who are pushing the boundaries of cancer science. These talented innovators are receiving prestigious four-year fellowships to pursue groundbreaking work that could transform how we understand and treat cancer.
Researchers have uncovered a revolutionary synthetic lethal strategy that exploits a genetic vulnerability in colorectal cancer cells, offering hope to the majority of patients with APC mutations. This breakthrough could fundamentally transform how we approach treatment for one of the world's most common cancers.
Scientists have uncovered a shocking discovery: brain cells that normally support nerve function are actually helping deadly glioblastoma tumors grow and spread. By blocking the signals between these cells and cancer cells, researchers may have found a new way to fight one of the most aggressive brain cancers.
Australian researchers have cracked a crucial mystery: peritoneal mesothelioma creates a special shield that makes it invisible to immunotherapy treatments. This discovery could change how doctors approach treatment for this aggressive cancer.
Scientists have discovered a fascinating—and troubling—reason why cancer manages to outsmart our immune defenses: tumors are actively draining the energy from dendritic cells, the critical soldiers in our body's cancer-fighting arsenal. By targeting these cells' mitochondria, cancer creates an internal power crisis that leaves your immune system unable to mount an effective attack.
Scientists have discovered a powerful new way to predict whether breast cancer patients are likely to experience a relapse—by analyzing fragments of tumor DNA in their bloodstream. This breakthrough could revolutionize how doctors monitor and treat breast cancer patients after surgery.
Targeted cancer therapies are revolutionary—but they fail for up to 60% of patients who should benefit from them. New research from MIT is finally explaining why, and the answer could transform how we treat cancer.
Every week, researchers announce promising new cancer therapies—but most never make it to patients. Discover what separates genuine clinical advances from interesting science, and why the standards for publishing cancer research matter more than ever.